References:
- Toussi A, Mans N, Welborn J, and Kiuru M. Germline mutations
predisposing to
melanoma. J Cutan Pathol . 2020 Jul;47(7):606-616.
- Goldstein AM, Xiao Y, Sampson J, Zhu B, Rotunno M, Bennett H, Wen Y,
Jones K, Vogt A, Burdette L, Luo W, Zhu B, Yeager M, Hicks B, Han J,
De Vivo I, Koutros S, Andreotti G, Beane-Freeman L, Purdue M, Freedman
ND, Chanock SJ, Tucker MA, Yang XR, Rare germline variants in known
melanoma susceptibility genes in familial melanoma, Human
Molecular Genetics , Volume 26, Issue 24, 15 December 2017, Pages
4886–4895.
- Renwick A, Thompson D, Seal S,. et al. ATM mutations
that cause ataxia-telangiectasia are breast cancer susceptibility
alleles. Nat Genet 38, 873–875 (2006).
- Hall MJ, Bernhisel R,
Hughes E, Larson K. Germline Pathogenic Variants
in the Ataxia Telangiectasia Mutated (ATM ) Gene are Associated
with High and Moderate Risks for Multiple Cancers. Cancer Prevention
Research. (2021) 14 (4): 433-440.
- NCCN Clinical Practice Guidelines in Oncology®: Genetic/Familial
High-Risk Assessment: Breast and Ovarian. Version 3.2019.
- Navid F, Herzog CE, Sandoval J, et al. Feasibility of Pegylated
Interferon in Children and Young Adults With Resected High-Risk
Melanoma. Pediatr Blood Cancer 2016:63(7):1207–1213
- Chang W, Brohl AS, Patidar R, et al. Multidimensional ClinOmics for
precision therapy of children and adolescent young adults with
relapsed and refractory cancer: a report from the center for cancer
research. Clin Cancer Res. 2016;22(15):3810‐3820.
- Everett JN, Mody RJ, Stoffel EM, Chinnaiyan AM. Incorporating genetic
counseling into clinical care for children and adolescents with
cancer. Future Oncol. 2016;17(7):883‐886
- Parsons DW, Roy A, Yang Y, et al.Diagnostic Yield of Clinical Tumor
and Germline Whole-Exome Sequencing for Children With Solid Tumors.
JAMA Oncol 2 (5): 616-624, 2016.
- Zhang J, Walsh MF, Wu G, et al.Germline Mutations in Predisposition
Genes in Pediatric Cancer. N Engl J Med 373 (24): 2336-46, 2015
- Villani A, Tabori U, Schiffman J, Shlien A, Beyene J, Druker H,
Novokmet A, Finlay J, Malkin D. Biochemical and imaging surveillance
in germline TP53 mutation carriers with Li-Fraumeni syndrome: a
prospective observational study. Lancet Oncol. 2011
Jun;12(6):559-67.
- Schneider K, Zelley K, Nichols KE, et al. Li-Fraumeni Syndrome. 1999
Jan 19 [Updated 2019 Nov 21]. In: Adam MP, Everman DB, Mirzaa GM,
et al., editors. GeneReviews® [Internet]. Seattle (WA): University
of Washington, Seattle; 1993-2022.
- Aronson M, Colas C, Shuen A, Hampel H, Foulkes WD, Feldman HB,
Goldberg Y, Muleris M, Schneider KW, McGee RB, Jasperson K, Rangaswami
A, Brugieres L, Tabori U. Diagnostic criteria for constitutional
mismatch repair deficiency (CMMRD): recommendations from the
international consensus working group. Journal of Medical
Genetics 2022;59:318-327.
- Koolen DA, Morgan A, de Vries BBA. Koolen-de Vries Syndrome. In: Adam
MP, Mirzaa GM, Pagon RA, et al. GeneReviews® . Seattle (WA):
University of Washington, Seattle; January 26, 2010.
- Tabori U, Hansford RJ, Achatz MI, Kratz CP, Plon SE, Frebourg T,
Brugireres L. Clinical Management and Tumor Surveillance
Recommendation of Inherited Mismatch Repair Deficiency in Childhood.
Clinical Cancer Research. (2017) 23 (11);e32-e37.
- Dalmasso B, Pastorino L, Nathan V, et al. Germline ATM variants
predispose to melanoma: a joint analysis across the GenoMEL and
MelaNostrum consortia. Genetics in Medicine. Volume 23, Issue 11 2021
(2087-2095. 1098-3600
- Tuominen R, Engström PG, Helgadottir H, et al. The role of germline
alterations in the DNA damage response genes BRIP1 and BRCA2 in
melanoma susceptibility. Genes Chromosomes Cancer .
2016;55(7):601-611. doi:10.1002/gcc.22363
- Pellegrini C, Raimondi S, Di Nardo L, et al. Melanoma in children and
adolescents: analysis of susceptibility genes in 123 Italian
patients. J Eur Acad Dermatol Venereol .
2022;36(2):213-221.doi:10.1111/jdv.17735